Related Experiment Videos

Steroids ineffective for pain in children with pharyngitis

R Marc Via1

  • 1Department of Family and Community Medicine, Scott and White Memorial Hospital, Texas A and M University Health Science Center College of Medicine, Temple, TX, USA. mvia@swmail.sw.org

The Journal of Family Practice
|August 6, 2003
PubMed

Insights

Oral dexamethasone offers limited pain relief for acute pharyngitis in children. Its use is questionable, even for severe cases of streptococcus pharyngitis.

Area of Science:

  • Pediatric Emergency Medicine
  • Pharmacology
  • Infectious Diseases

Background:

  • Acute pharyngitis is a common pediatric illness.
  • Oral dexamethasone is sometimes used for pain management in children with pharyngitis.

Discussion:

  • This study evaluated the efficacy of oral dexamethasone in reducing pain in children with acute pharyngitis.
  • The findings indicate that dexamethasone does not significantly shorten the time to pain relief.

Key Insights:

  • Oral dexamethasone does not provide clinically significant pain reduction for acute pharyngitis in children.
  • Consider dexamethasone for severe group A beta-hemolytic streptococcus pharyngitis, but benefits are marginal.

Outlook:

  • Further research may explore alternative pain management strategies for pediatric pharyngitis.
  • Clinical guidelines may need revision regarding dexamethasone use in this population.

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: